Matuzumab

Matuzumab

Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associated with the growth of blood vessels in malignancy facilitating tumor growth and survival.

 

 

[accordions]
[accordion title= “Chemical Properties“]

Molecular Weight N/A
CAS No. 339186-68-4

[/accordion]

 

 

 

[accordions]
[accordion title= “References and Literature“]

1. Rob C. Roovers, et al. A bi-paratopic anti-EGFR nanobody efficiently inhibits solid tumour growth.Int J Cancer. 2011 Oct 15; 129(8): 2013–2024.

[/accordion]